CCXI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CCXI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Unearned Premiums only applies to insurance companies.
Susan M Kanaya | officer: SVP Finance, CFO & Secretary | 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 |
Thomas J. Schall | director, 10 percent owner, officer: President, CEO and Director | 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 |
Jennifer Lyn Herron | director | C/O GENOCEA BIOSCIENCES, INC., 100 ACORN PARK DRIVE 5TH FLOOR, CAMBRIDGE MA 02140 |
James L Tyree | director | 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064-6400 |
Yi Ching Yau | officer: SVP, Finance & Acctg Officer | C/O BRIDGEBIO PHARMA, INC., 421 KIPLING STREET, PALO ALTO CA 94301 |
David E. Wheadon | director | C/O ASSERTIO THERAPEUTICS, INC., 100 SOUTH SAUNDERS ROAD, SUITE 300, LAKE FOREST IL 60045 |
Vifor (international) Ltd | 10 percent owner | RECHENSTRASSE 37, ST. GALLEN V8 9000 |
Tausif Butt | officer: EVP, Chief Operating Officer | C/O CHEMOCENTRYX, INC. 850 MAUDE AVE. MOUNTAIN VIEW CA 94043 |
Geoffrey M. Parker | director | 15 RIORDAN PLACE, MENLO PARK CA 94025 |
Thomas A. Edwards | director | C/O CHEMOCENTRYX, INC. 850 MAUDE AVE. MOUNTAIN VIEW CA 94043 |
Markus J. Cappel | officer: CBO and Treasurer | 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 |
Pui San Kwan | officer: Principal Acctg Officer | 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 |
Rajinder Singh | officer: SVP, Research | C/O CHEMOCENTRYX, INC. 850 MAUDE AVE. MOUNTAIN VIEW CA 94043 |
Rita Jain | director | C/O AKEBIA THERAPEUTICS, INC., 245 FIRST STREET, SUITE 1100, CAMBRIDGE MA 02142 |
Vifor Pharma Ltd. | 10 percent owner | UNTERMATTWEG 8, BERNE V8 CH-3027 |
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.